Comparison of cost-effectiveness of preventive and reactive mass immunization campaigns against meningococcal meningitis in West Africa: a theoretical modeling analysis-Reference-Cited by-同舟云学术

Comparison of cost-effectiveness of preventive and reactive mass immunization campaigns against meningococcal meningitis in West Africa: a theoretical modeling analysis

Published:2001-05 Issue:25-26 Volume:19 Page:3420-3431
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Parent du Châtelet Isabelle,Gessner Bradford D,da Silva Alfred

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference43 articles.

1. La méningite cérébrospinale en Afrique;Lapeyssonnie;Bull. World Health Org.,1963

2. Response to epidemic meningitis in Africa, 1997;Weekly Epidemiol. Rec.,1997

3. Optimiser la riposte aux épidémies de méningite à méningocoque: rapport d'un atelier d'experts réuinis au CERMES (12 au 14 jenvier 1998, Niamey, Niger);Chippaux;Cahiers Santé,1998

4. A predictable comeback: the second pandemic of infections caused by Neisseria meningitidis serogroup A subgroup III in Africa, 1995;Riou;Bull. World Health Org.,1996

5. The 1998 Senegal epidemic of meningitis was due to the clonal expansion of A:4:P1.9, clone III-1, sequence type 5 Neisseria meningitides strains;Nicolas;J. Clin. Microbiol.,2000

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Economic evaluation on meningococcal vaccination strategies among children under nine years of age in Zhejiang province, China;PLOS ONE;2024-09-09

2. Cost-effectiveness analysis of vaccination strategies against meningococcal disease for children under nine years of age in China;Human Vaccines & Immunotherapeutics;2024-02-13

3. A Systematic Review of the Incremental Costs of Implementing a New Vaccine in the Expanded Program of Immunization in Sub-Saharan Africa;MDM Policy & Practice;2019-07

4. Challenges and opportunities for meningococcal vaccination in the developing world;Human Vaccines & Immunotherapeutics;2018-02-23

5. The cost-effectiveness of alternative vaccination strategies for polyvalent meningococcal vaccines in Burkina Faso: A transmission dynamic modeling study;PLOS Medicine;2018-01-24